As usual, the truth is likely somewhere in the middle. If some smaller generic manufacturers and distributors leave the market, that won't be a tragedy because many others remain. The government may need to target tendering to certain products to ensure that non-tendered products contribute sufficient margins to keep drug manufacturers profitable. And don't forget that QC sits in a national market and it will take time for other provinces to observe and perhaps join. That gives the industry time to adjust and retains other markets for them (some international) with higher margins, at least for the short term.

There's a lot of rhetoric from both sides in these early days. It will shake out in time and hopefully Quebec and then Canada will be paying much lower prices.